What's new? Log in Free sign up

Filing search / VBI Vaccines Inc / "Training"

Search information

VBI Vaccines Inc

Companies

"Training"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

55 results

Newest first Best match first

VBIVQ VBI Vaccines Inc

Definitive proxy

of the board until 1997. Amgen, Inc. acquired Immunex in 2002. Dr. Gillis is an immunologist by training with over 300 peer-reviewed publications … of Guadalajara, completed fellowship training in Infectious Diseases at the University of Manitoba, and earned a Ph.D. in Virology from the University

29 Apr 24

4:05pm

VBIVQ VBI Vaccines Inc

in identifying, recruiting, and training suitable clinical investigators; delays in recruiting suitable patients to participate in a trial; delays in having … undergone specialized training, limiting treatment to patients who meet certain safe-use criteria and requiring treated patients to enroll

16 Apr 24

8:01am

VBIVQ VBI Vaccines Inc

Prospectus supplement for primary offering

they reach the age of 40 (or older, for reservists who are officers or who have certain special training) and, in the event of a military conflict, may

VBIVQ VBI Vaccines Inc

Quarterly report

shall commence meeting with such Secondary Manufacturer, providing training, technical support, and continued delivery of any Manufacturing Technology … or embodiments of Manufacturing Technology, participating in ongoing discussions, and providing in-person support and training. VBI’s contribution

14 Nov 23

4:06pm

VBIVQ VBI Vaccines Inc

Quarterly report

commence meeting with such Secondary Manufacturer, providing training, technical support, and continued delivery of any Manufacturing Technology … or embodiments of Manufacturing Technology, participating in ongoing discussions, and providing in-person support and training. VBI’s contribution

14 Nov 23

4:06pm

Definitive proxy

1 May 23

4:05pm

VBI Vaccines Announces Appointment of John Dillman as Chief Commercial Officer

gn2amnyfkln4mizu

Definitive proxy

29 Apr 22

4:51pm

Preliminary proxy

18 Apr 22

4:45pm

slp6nt1si90m589uvmq

7 Mar 22

8:01am

7 Mar 22

8:01am

pbr0om1bs0b1meb ibw

Definitive proxy

26 Apr 21

9:00am

2 Mar 21

8:00am

k2g5tnc mje9ldz

2 Mar 21

8:00am

VBI Vaccines Selects Syneos Health as Commercialization Partner for Prophylactic 3-Antigen Hepatitis B Vaccine

Quarterly report

2 Nov 20

8:00am

Quarterly report

6 May 20

8:06am

azeno8pjxr96um28ry

Definitive proxy

28 Apr 20

4:05pm

7lctt5grizp1u4jq3rec

5 Mar 20

8:11am

Prospectus supplement for primary offering

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.